HIGHLIGHTS
- who: Markus Bredel et al. from the Department of Radiation Oncology, O`Neal Comprehensive Cancer Center, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA have published the paper: An ErbB Lineage Co-Regulon Harbors Potentially Co-Druggable Targets for Multimodal Precision Therapyin Head and Neck Squamous Cell Carcinoma, in the Journal: (JOURNAL)
- future: The authors found this co-regulon is highly enriched for functions in chromatin remodeling and histone modifications and harbors potentially actionable co-druggable targets and response biomarkers for future investigations of multimodal precision therapy.
SUMMARY . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.